Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 3Breast 3Plasma cell 2Gastrointestinal 2Myeloid 1

Conditions

Stomach Neoplasms 1Postoperative Complications 1Colorectal Neoplasms 1

Interventions

Oxaliplatin 297Fluorouracil 272Bevacizumab 235Gemcitabine 234Leucovorin 212Capecitabine 204pembrolizumab 200Nivolumab 157Irinotecan 156Cisplatin 148Specimen Handling 143Magnetic Resonance Spectroscopy 130130-nm albumin-bound paclitaxel 115Paclitaxel 109durvalumab 104Cetuximab 102Radiotherapy 96atezolizumab 92Biopsy 92Drug Therapy 91Albumin-Bound Paclitaxel 78tislelizumab 77Taxes 73Folfox protocol 68lenvatinib 67Carboplatin 65regorafenib 60Blood Specimen Collection 60trifluridine tipiracil drug combination 52Ipilimumab 52

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Clinical Protocols × Gastrointestinal × 1 year × Clear all
NCT07496528 2026-04-06

ACURE

Chang Gung Memorial Hospital

Phase NA Not yet recruiting
240 enrolled
Gastrointestinal

Postoperative Complications, Colorectal Neoplasms

NCT07328633 2026-01-09

Prehabilitation Plus ERAS in Gastric Cancer Surgery

The Affiliated Hospital of Qingdao University

Phase NA Completed
136 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡